AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Heart Circ Physiol 268: H517-H525, 1995;
0363-6135/95 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kapadia, S.
Right arrow Articles by Mann, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kapadia, S.
Right arrow Articles by Mann, D. L.

AJP - Heart and Circulatory Physiology, Vol 268, Issue 2 517-H525, Copyright © 1995 by American Physiological Society

ARTICLES

Soluble TNF binding proteins modulate the negative inotropic properties of TNF-alpha in vitro

S. Kapadia, G. Torre-Amione, T. Yokoyama and D. L. Mann
Department of Medicine, Veterans Administration Medical Center, Houston, Texas.

Soluble tumor necrosis factor (TNF) binding proteins (TNF-BPs) were characterized with respect to their capacity to modulate the negative inotropic properties of TNF-alpha in isolated contracting cardiac myocytes. Three TNF-BPs were evaluated: two natural monomeric human TNF monomeric binding proteins, TNF-BP1 and TNF-BP2, and sTNFR:Fc, a dimer of two molecules of human TNF-BP2 linked by the Fc portion of the human immunoglobulin G1 molecule. When TNF-alpha (25 pM) was allowed to form TNF-BP-TNF-alpha complexes, the negative inotropic effects of TNF-alpha were completely prevented by "neutralizing concentrations" of TNF-BPs, whereas lesser concentrations of TNF-BPs only partially attenuated the negative inotropic effects of TNF-alpha. The dimeric binding protein sTNFR:Fc was more effective on a molar basis than either of the monomeric binding proteins (TNF-BP1 or TNF-BP2) with respect to blocking the negative inotropic effects of TNF-alpha. When cardiac myocytes that had been treated with TNF-alpha (25 pM) were exposed to neutralizing concentrations of TNF-BP1, TNF-BP2, and sTNFR:Fc, the negative inotropic effects were completely reversed within 30 min. Thus these studies show for the first time that TNF-BPs are sufficient to prevent, as well as reverse, the negative inotropic properties of TNF-alpha in vitro.


This article has been cited by other articles:


Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
C. Berthonneche, T. Sulpice, F. Boucher, L. Gouraud, J. de Leiris, S. E. O'Connor, J.-M. Herbert, and P. Janiak
New insights into the pathological role of TNF-{alpha} in early cardiac dysfunction and subsequent heart failure after infarction in rats
Am J Physiol Heart Circ Physiol, July 1, 2004; 287(1): H340 - H350.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
C G Densem, I V Hutchinson, N Yonan, and N H Brooks
Tumour necrosis factor {alpha} gene polymorphism: a predisposing factor to non-ischaemic myocardial dysfunction?
Heart, February 1, 2002; 87(2): 153 - 155.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
P. O. Iversen, G. Nicolaysen, and M. Sioud
DNA enzyme targeting TNF-alpha mRNA improves hemodynamic performance in rats with postinfarction heart failure
Am J Physiol Heart Circ Physiol, November 1, 2001; 281(5): H2211 - H2217.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
M. Okuyama, S. Yamaguchi, M. Yamaoka, J. Nitobe, S. Fujii, T. Yoshimura, and H. Tomoike
Nitric Oxide Enhances Expression and Shedding of Tumor Necrosis Factor Receptor I (p55) in Endothelial Cells
Arterioscler. Thromb. Vasc. Biol., June 1, 2000; 20(6): 1506 - 1511.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
T. Kubota, G. S. Bounoutas, M. Miyagishima, T. Kadokami, V. J. Sanders, C. Bruton, P. D. Robbins, C. F. McTiernan, and A. M. Feldman
Soluble Tumor Necrosis Factor Receptor Abrogates Myocardial Inflammation but Not Hypertrophy in Cytokine-Induced Cardiomyopathy
Circulation, May 30, 2000; 101(21): 2518 - 2525.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
R. Shahani, J. G. Marshall, B. B. Rubin, R.-K. Li, P. M. Walker, and T. F. Lindsay
Role of TNF-alpha in myocardial dysfunction after hemorrhagic shock and lower-torso ischemia
Am J Physiol Heart Circ Physiol, March 1, 2000; 278(3): H942 - H950.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
X. Meng, L. Ao, D. R. Meldrum, B. S. Cain, B. D. Shames, C. H. Selzman, A. Banerjee, and A. H. Harken
TNF-alpha and myocardial depression in endotoxemic rats: temporal discordance of an obligatory relationship
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 1998; 275(2): R502 - R508.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
X. Meng, L. Ao, J. M. Brown, D. R. Meldrum, B. C. Sheridan, B. S. Cain, A. Banerjee, and A. H. Harken
LPS induces late cardiac functional protection against ischemia independent of cardiac and circulating TNF-alpha
Am J Physiol Heart Circ Physiol, October 1, 1997; 273(4): H1894 - H1902.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
M. Packer
Is Tumor Necrosis Factor an Important Neurohormonal Mechanism in Chronic Heart Failure?
Circulation, September 15, 1995; 92(6): 1379 - 1382.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online